Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males

American Journal of Public Health

Volumn 103, Issue 8, 2013, Pages 1419-1427

  Reiter, Paul L ^a   McRee, Annie Laurie ^b   Pepper, Jessica K ^c   Gilkey, Melissa B ^d   Galbraith, Kayoll V ^d   Brewer, Noel T ^c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c IL   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; ATTITUDE TO HEALTH; CHI SQUARE DISTRIBUTION; CHILD; HUMAN; LONGITUDINAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; UNITED STATES;

ADOLESCENT; CHI-SQUARE DISTRIBUTION; CHILD; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LONGITUDINAL STUDIES; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UNITED STATES;

EID: 84880174108     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2012.301189     Document Type: Article

References (42)

1. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006;24(Suppl 3): 35-41.
2. Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009;124(10): 2375-2383.
3. Gardasil. US Food and Drug Administration. 2011. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094042. htm. Accessed May 10, 2012.
4. Dinh TH, Sternberg M, Dunne EF, Markowitz LE. Genital warts among 18- to 59-year-olds in the United States, National Health and Nutrition Examination Survey, 1999-2004. Sex Transm Dis. 2008;35(4): 357-360.
5. American Cancer Society. Cancer Facts & Figures 2012. Atlanta, GA: American Cancer Society; 2012.
6. Reiter PL, Pendergraft WF III, Brewer NT. Meta-analysis of human papillomavirus infection concordance. Cancer Epidemiol Biomarkers Prev. 2010;19(11): 2916-2931.
7. Elbasha EH, Dasbach EJ. Impact of vaccinating boys and men against HPV in the United States. Vaccine. 2010;28(42):6858-6867.
8. Centers for Disease Control and Prevention. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59 (20):630-632.
9. Centers for Disease Control and Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(50):1705-1708.
10. Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546-3556.
11. Liddon N, Hood J, Wynn BA, Markowitz LE. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health. 2010;46 (2):113-123.
12. Dempsey AF, Butchart A, Singer D, Clark S, Davis M. Factors associated with parental intentions for male human papillomavirus vaccination: results of a national survey. Sex Transm Dis. 2011;38(8):769-776.
13. Reiter PL, McRee AL, Gottlieb SL, Brewer NT. HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine. 2010;28(38):6292-6297.
14. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13 through 17 years-United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(33):1117-1123.
15. Reiter PL, McRee AL, Kadis JA, Brewer NT. HPV vaccine and adolescent males. Vaccine. 2011;29 (34):5595-5602.
16. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13-17 years-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(34):671-677.
17. McRee AL, Reiter PL, Brewer NT. Vaccinating adolescent girls against human papillomavirus-who decides? Prev Med. 2010;50(4):213-214.
18. Dennis JM. KnowledgePanel Design Summary. 2010. Available at: http://www.knowledgenetworks.com/knpanel/docs/KnowledgePanel(R) -Design-Summary-Description.pdf. Accessed May 5, 2012.
19. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. 7th ed. Deerfield, IL: American Association for Public Opinion Research; 2011.
20. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69(3):475-480.
21. Keating KM, Brewer NT, Gottlieb SL, Liddon N, Ludema C, Smith JS. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. J Adolesc Health. 2008;43 (4, suppl):S61-S67.
22. Fazekas KI, Brewer NT, Smith JS. HPV vaccine acceptability in a rural southern area. J Womens Health (Larchmt). 2008;17(4):539-548.
23. Gierisch JM, Reiter PL, Rimer BK, Brewer NT. Standard definitions of adherence for infrequent yet repeated health behaviors. Am J Health Behav. 2010;34 (6):669-679.
24. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2-3):107-114.
25. Brewer NT, Gottlieb SL, Reiter PL, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38(3):197-204.
26. Reiter PL, Brewer NT, Smith JS. Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sex Transm Infect. 2010;86(3):241-246.
27. Reiter PL, Brewer NT, McRee AL, Gilbert P, Smith JS. Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sex Transm Dis. 2010;37 (3):197-203.
28. Becker MH. The Health Belief Model and personal health behavior. Health Educ Monogr. 1974;2:324-473.
29. McRee AL, Brewer NT, Reiter PL, Gottlieb SL, Smith JS. The Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS): scale development and associations with intentions to vaccinate. Sex Transm Dis. 2010;37 (4):234-239.
30. Office of Management and Budget. Standards for defining metropolitan and micropolitan statistical areas; notice. Fed Regist. 2000;65(249):82227-82238.
31. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2008. MMWRMorb Mortal Wkly Rep. 2009;58(36):997-1001.
32. Centers for Disease Control and Prevention. Vaccination coverage among adolescents aged 13-17 years-United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(40):1100-1103.
33. Reiter PL, Cates JR, McRee AL, et al. Statewide HPV vaccine initiation among adolescent females in North Carolina. Sex Transm Dis. 2010;37(9):549-556.
34. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2): 1-24.
35. Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics. 2011;128(5):830-839.
36. Erratum in Pediatrics. 2012;130(1):166-168: dosage error in article text
37. Weiss TW, Zimet GD, Rosenthal SL, Brenneman SK, Klein JD. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. J Adolesc Health. 2010;47(1):3-11.
38. Nielson CM, Harris RB, Flores R, et al. Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1077-1083.
39. Gilbert P, Brewer NT, Reiter PL, Ng TW, Smith JS. HPV vaccine acceptability in heterosexual, gay, and bisexual men. Am J Mens Health. 2011;5(4): 297-305.
40. Schuler CL, Reiter PL, Smith JS, Brewer NT. Human papillomavirus vaccine and behavioural disinhibition. Sex Transm Infect. 2011;87(4):349-353.
41. Dorell CG, Jain N, Yankey D. Validity of parent-reported vaccination status for adolescents aged 13-17 years: National Immunization Survey-Teen, 2008. Public Health Rep. 2011;126(suppl 2):60-69.
42. Baker LC. Validity of the survey of health and Internet and Knowledge Network's panel and sampling. 2003. Available at: http://www.knowledgenetworks. com/ganp/docs/Appendix%20Survey%20of% 20Health%20and%20the%20Internet.pdf. Accessed May 5, 2012.